CIK 0000886744 · Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752287752
- Phone
- 6504737700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-25 | ROBERTSON MICHELLE EVP, Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +1,350,000 | 1,350,000 | ||
| 2023-08-24 | O'Farrell Elizabeth G. Director | Purchase | +6,607 | $2.28 | $15K | 7,407 |
| 2023-08-24 | O'Farrell Elizabeth G. Director | Purchase | +6,579 | $2.28 | $15K | 26,220 |
| 2023-08-15 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (Right to buy) | +500,000 | 500,000 | ||
| 2023-08-15 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +221,544 | 221,544 | ||
| 2023-08-15 | Feller Faye EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-08-15 | Feller Faye EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2023-08-15 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-08-01 | Samuels Scott Alan EVP, Chief Legal Officer | Grant or award · Employee Stock Option (right to buy) | +1,350,000 | 1,350,000 | ||
| 2023-06-30 | Molineaux Susan Director | Grant or award | +4,088 | 118,116 | ||
| 2023-06-30 | Spiegel Robert J. Director | Grant or award | +2,239 | 157,244 | ||
| 2023-06-30 | Kapur Anil EVP, Corp Strategy & CCO | Grant or award | +7,567 | $2.04 | $15K | 60,783 |
| 2023-05-31 | Bir Dawn Carter Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-31 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-31 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-31 | Molineaux Susan Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-31 | McDonald John F Director | Grant or award · Stock Options (right to buy) | +125,000 | 125,000 | ||
| 2023-05-31 | LAWLIS V BRYAN Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-11 | LAWLIS V BRYAN Director | Option exercise 10b5-1 | +35,000 | $1.10 | $39K | 35,000 |
| 2023-05-11 | LAWLIS V BRYAN Director | Sale 10b5-1 | −35,000 | $3.00 | $105K | 0 |
Page 6 of 7 · 138 trades